Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing Chemotherapy

Michael R Clausen,1 Matthew J Maurer,2 Sinna Pilgaard Ulrichsen,3 Thomas S Larsen,4 Bodil Himmelstrup,5 Dorthe Rønnov-Jessen,6 Brian K Link,7 Andrew L Feldman,8 Susan L Slager,2 Grzegorz S Nowakowski,9 Carrie A Thompson,9 Per Trøllund Pedersen,10 Jakob Madsen,11 Robert S Pedersen,12 Je...

詳細記述

書誌詳細

主要な著者:	Clausen MR, Maurer MJ, Ulrichsen SP, Larsen TS, Himmelstrup B, Rønnov-Jessen D, Link BK, Feldman AL, Slager SL, Nowakowski GS, Thompson CA, Pedersen PT, Madsen J, Pedersen RS, Gørløv JS, Cerhan JR, Nørgaard M, D'Amore F
フォーマット:	Artigo
言語:	Inglês
出版事項:	Dove Medical Press 2019-11-01
シリーズ:	Clinical Epidemiology
主題:	diffuse large b-cell lymphoma hemoglobin prognosis nccn-ipi
オンライン･アクセス:	https://www.dovepress.com/pretreatment-hemoglobin-adds-prognostic-information-to-the-nccn-ipi-in-peer-reviewed-article-CLEP
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!